1. Home
  2. CCL vs PODD Comparison

CCL vs PODD Comparison

Compare CCL & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carnival Corporation

CCL

Carnival Corporation

HOLD

Current Price

$27.75

Market Cap

34.2B

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$295.76

Market Cap

22.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCL
PODD
Founded
1972
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
22.1B
IPO Year
1987
2007

Fundamental Metrics

Financial Performance
Metric
CCL
PODD
Price
$27.75
$295.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
19
Target Price
$34.24
$359.00
AVG Volume (30 Days)
19.0M
791.4K
Earning Date
12-19-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
61.65
N/A
EPS
1.94
3.45
Revenue
$26,230,000,000.00
$2,521,800,000.00
Revenue This Year
$7.63
$32.55
Revenue Next Year
$4.33
$20.39
P/E Ratio
$14.25
$85.69
Revenue Growth
7.15
27.11
52 Week Low
$15.07
$230.05
52 Week High
$32.80
$354.88

Technical Indicators

Market Signals
Indicator
CCL
PODD
Relative Strength Index (RSI) 57.80 38.33
Support Level $25.27 $290.98
Resistance Level $26.15 $306.04
Average True Range (ATR) 0.87 9.59
MACD 0.32 -3.01
Stochastic Oscillator 85.61 9.03

Price Performance

Historical Comparison
CCL
PODD

About CCL Carnival Corporation

Carnival is the largest global cruise company, with more than 90 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: